The analysis reveals that PD-L1 is highly expressed in enzalutamide-resistant PCa cell lines, such as C4-2B MDVR and PC-3, where it strongly correlates with enhanced immune evasion by tumor cells. The gene discussed is CD274; the disease is neoplasm.